Related Experiment Videos
Studies on combination dosing (III). Aspirin and ethenzamide
Japanese Journal of Pharmacology
|December 1, 1978
Summary
Aspirin combined with ethenzamide enhances pain relief and reduces side effects. This drug combination, particularly at a 2:3 ratio, shows improved safety and efficacy for analgesic use.
Area of Science:
- Pharmacology
- Drug Discovery
- Gastroenterology
Background:
- Drug combinations are explored to boost therapeutic effectiveness.
- Aspirin is a common analgesic with known gastrointestinal side effects.
Purpose of the Study:
- To investigate the synergistic effects of drug combinations.
- To evaluate ethenzamide's potential to mitigate aspirin-induced gastric damage.
- To assess the impact of aspirin-ethenzamide combination on analgesic activity and safety.
Main Methods:
- Testing ethenzamide's effect on aspirin-induced gastric damage in preclinical models.
- Comparing ethenzamide with other analgesics (salicylamide, bucetin, acetaminophen, phenacetin).
- Evaluating analgesic potentiation, motor coordination, and righting reflex in combination studies.
- Calculating safety margins for various aspirin-ethenzamide ratios.
Main Results:
- Ethenzamide specifically suppressed aspirin-induced gastric damage.
- No similar protective effect was observed with other tested analgesics.
- The aspirin-ethenzamide combination potentiated analgesic effects and reduced side effects like motor incoordination.
- An optimal safety margin was identified for a 2:3 ratio of aspirin to ethenzamide.
Conclusions:
- Ethenzamide demonstrates gastroprotective properties against aspirin.
- The combination of aspirin and ethenzamide offers enhanced analgesic efficacy with improved safety.
- A 2:3 ratio of aspirin to ethenzamide is recommended for optimal therapeutic benefit and safety.